Grant: Planning and Dissemination Grant - Institute Community Support
York University (Toronto, Ontario)
$15,000.00
Canadian Rare Disease Innovation Showcase
EF 2024-25
Résumé
The Canadian Rare Disease Network (CRDN) - Réseau Canadien des Maladies Rares - has emerged as a strategic pan-Canadian, cross-disciplinary network uniting the country's leading clinical, scientific, and patient expertise to improve the lives of over three million children and adults affected by rare diseases (RD) in Canada. Its comprehensive research-to-care framework bridges research, diagnosis, treatment, care, psychosocial support, and other essential aspects of holistic care to enhance collective impact.
The proposed Canadian Rare Disease Innovation Showcase ("the Showcase") will highlight advancements in RD research and care, featuring rapid-fire talks on cutting-edge developments and their potential to improve patient outcomes. The Showcase will also serve as a platform for networking and partnership building among patients, families, healthcare professionals, researchers, and policymakers, facilitating the exchange of knowledge and best practices. It is also expected to raise awareness among policymakers about the latest advancements and opportunities, ultimately leading to more informed and supportive health policies, beyond the current focus on RD drugs.
Emphasizing equity, diversity, inclusion, and accessibility (EDIA), the Showcase will ensure diverse representation among speakers and participants and bilingual accessibility, wherever possible, to engage the Francophone community. Given the current momentum in the RD space in Canada given the National Strategy for Drugs for RD, and increasing public interest, we anticipate a substantial interest from the RD community, with an expected attendance of 80-100 in-person participants in Ottawa and about 200 virtual attendees nationwide. This event will foster a more unified and collaborative RD community, improving knowledge exchange, facilitating connections, and informing health policy to better address RD challenges in Canada.
Programme
Planning and Dissemination Grant - Institute Community Support
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
508053
Name
Stedman Ian
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Planning and Dissemination Grants
Projecttitle
Canadian Rare Disease Innovation Showcase
Programtype2
Miscellaneous Programs
Orgnameinp2
York University (Toronto, Ontario)
Cihramount2
$15,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Care; Diagnostics; Genetics; Patient Partnership; Policy; Precision Medicine; Rare Diseases; Research; Therapies
Abstract
The Canadian Rare Disease Network (CRDN) - Réseau Canadien des Maladies Rares - has emerged as a strategic pan-Canadian, cross-disciplinary network uniting the country's leading clinical, scientific, and patient expertise to improve the lives of over three million children and adults affected by rare diseases (RD) in Canada. Its comprehensive research-to-care framework bridges research, diagnosis, treatment, care, psychosocial support, and other essential aspects of holistic care to enhance collective impact.
The proposed Canadian Rare Disease Innovation Showcase ("the Showcase") will highlight advancements in RD research and care, featuring rapid-fire talks on cutting-edge developments and their potential to improve patient outcomes. The Showcase will also serve as a platform for networking and partnership building among patients, families, healthcare professionals, researchers, and policymakers, facilitating the exchange of knowledge and best practices. It is also expected to raise awareness among policymakers about the latest advancements and opportunities, ultimately leading to more informed and supportive health policies, beyond the current focus on RD drugs.
Emphasizing equity, diversity, inclusion, and accessibility (EDIA), the Showcase will ensure diverse representation among speakers and participants and bilingual accessibility, wherever possible, to engage the Francophone community. Given the current momentum in the RD space in Canada given the National Strategy for Drugs for RD, and increasing public interest, we anticipate a substantial interest from the RD community, with an expected attendance of 80-100 in-person participants in Ottawa and about 200 virtual attendees nationwide. This event will foster a more unified and collaborative RD community, improving knowledge exchange, facilitating connections, and informing health policy to better address RD challenges in Canada.
Competitiondate
202408
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stedman, Ian
Approvedterm
1 an 0 mois
Cihrcontribution2
IG~ $15,000~ $0~